Management and Considerations for Cardiopulmonary Bypass in Patients With Suspected Cold Agglutinin Disease
Abstract：Cold agglutinin disease (CAD) is a rare immune disease mediated by autoantibodies called cold agglutinins (CAs), characterized by reversible agglutination of red blood cells under specific low-temperature conditions, leading to microcirculatory impairment and hemolysis risk. Clinically, the highest temperature at which red blood cell agglutination occurs is defined as the thermal amplitude (TA)[1].
Keywords：cold agglutinin diseasethermal amplitudecardiopulmonary bypassperfusion strategy
Publication Date：2025-12-28
Online Publishing Date：2026-01-16(First online date of this platform, not the publication date of the document)
Pages：3( 515-517 )